Tuesday, June, 25, 2019 07:55:23

Neon Therapeutics unveils new data in clinical trial of cancer vaccine

The study will evaluate the combination of NEO-PV-01 with nivolumab (anti-PD-1 therapy) in metastatic or advanced melanoma patients Neon Therapeutics Inc., an immuno-oncology company which develops neoantigen-based treatments has reportedly presented updated data that describes pathologic and immune markers related with durable clinical advantages in …

Theravance’s Ampreloxetine clinical data to be presented at 32nd ENC

The clinical data would be coming from the company’s phase-2 ampreloxetine clinical trials. The 20-week-long data supports a previously announced medical observation after approximately four weeks of therapy. Theravance Biopharma, Inc., (Theravance Biopharma), a renowned diversified biopharmaceutical company, has reportedly announced the outcome of the …

Dermira to launch new campaign called ‘Life Unfolds’ featuring QBREXZA

The latest multi-channel consumer campaign is likely to feature several QBREXZA patients Dermira Inc., a US-based biopharmaceutical company, is currently in the news for introducing a brand-new direct-to-consumer campaign known as ‘Life Unfolds’, which has been strategized to spread awareness of QBREXZA™ treatment. As per …

Zulresso wins FDA approval as the first post-partum depression drug

Zulresso will be provided through a restricted program in which a healthcare expert administers the drug in an authorized health facility Reports confirm that the U.S. Food and Drug Administration has recently approved Zulresso injection for the treatment of Post-Partum depression (PPD) in adult women. …